Sienna Cancer Diagnostics Ltd operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sienna Cancer Diagnostics Ltd with three other
pharmaceutical manufacturers in Australasia:
sales of 956,472.00 Australian Dollars [US$657,823.18 ]
MGC Pharmaceuticals Ltd
(858,087.00 Australian Dollars [US$590,157.92 ]
Auscann Group Holdings Ltd
(861,770.00 Australian Dollars [US$592,690.94 ]
During the year ended June of 2019, sales at
Sienna Cancer Diagnostics Ltd were A$1.18 million (US$814.09 thousand).
decrease of 8.6%
versus 2018, when the company's sales were A$1.30 million.